ID   G3P_MOUSE               Reviewed;         333 AA.
AC   P16858; A6H6A8; Q0QEU0; Q3THM2; Q3TUI2; Q3UMT2; Q4V783; Q569X2; Q569X5;
AC   Q5U410;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   18-JUN-2025, entry version 231.
DE   RecName: Full=Glyceraldehyde-3-phosphate dehydrogenase;
DE            Short=GAPDH;
DE            EC=1.2.1.12 {ECO:0000269|PubMed:19903941};
DE   AltName: Full=Peptidyl-cysteine S-nitrosylase GAPDH {ECO:0000305};
DE            EC=2.6.99.- {ECO:0000250|UniProtKB:P04797};
GN   Name=Gapdh; Synonyms=Gapd;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2145197; DOI=10.1016/0378-1119(90)90087-8;
RA   Sabath D.E., Broome H.E., Prystowsky M.B.;
RT   "Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-
RT   induced transcript in a cloned T-helper lymphocyte.";
RL   Gene 91:185-191(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=BALB/cJ, C57BL/6J, and DBA/2J;
RC   TISSUE=Cerebellum, Eye, Head, Kidney, and Lung;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=129, C57BL/6J, Czech II, FVB/N, and FVB/N-3;
RC   TISSUE=Brain, Colon, Embryo, Eye, Mammary gland, and Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 4-11; 27-50; 65-78; 85-105; 116-137; 144-189; 199-213;
RP   218-246 AND 262-333, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=C57BL/6J, and OF1; TISSUE=Brain, and Hippocampus;
RA   Lubec G., Kang S.U., Klug S., Yang J.W., Zigmond M., Sunyer B., Chen W.-Q.;
RL   Submitted (JAN-2009) to UniProtKB.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 24-249.
RX   PubMed=16751257; DOI=10.1093/molbev/msl027;
RA   Kullberg M., Nilsson M.A., Arnason U., Harley E.H., Janke A.;
RT   "Housekeeping genes for phylogenetic analysis of eutherian relationships.";
RL   Mol. Biol. Evol. 23:1493-1503(2006).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, SULFHYDRATION AT CYS-150, AND MUTAGENESIS OF
RP   CYS-150.
RX   PubMed=19903941; DOI=10.1126/scisignal.2000464;
RA   Mustafa A.K., Gadalla M.M., Sen N., Kim S., Mu W., Gazi S.K., Barrow R.K.,
RA   Yang G., Wang R., Snyder S.H.;
RT   "H2S signals through protein S-sulfhydration.";
RL   Sci. Signal. 2:RA72-RA72(2009).
RN   [8]
RP   FUNCTION, SUBUNIT, AND RECONSTITUTION OF THE GAIT COMPLEX.
RX   PubMed=23071094; DOI=10.1128/mcb.01168-12;
RA   Arif A., Chatterjee P., Moodt R.A., Fox P.L.;
RT   "Heterotrimeric GAIT complex drives transcript-selective translation
RT   inhibition in murine macrophages.";
RL   Mol. Cell. Biol. 32:5046-5055(2012).
CC   -!- FUNCTION: Has both glyceraldehyde-3-phosphate dehydrogenase and
CC       nitrosylase activities, thereby playing a role in glycolysis and
CC       nuclear functions, respectively (PubMed:19903941). Glyceraldehyde-3-
CC       phosphate dehydrogenase is a key enzyme in glycolysis that catalyzes
CC       the first step of the pathway by converting D-glyceraldehyde 3-
CC       phosphate (G3P) into 3-phospho-D-glyceroyl phosphate (PubMed:19903941).
CC       Modulates the organization and assembly of the cytoskeleton (By
CC       similarity). Facilitates the CHP1-dependent microtubule and membrane
CC       associations through its ability to stimulate the binding of CHP1 to
CC       microtubules (By similarity). Component of the GAIT (gamma interferon-
CC       activated inhibitor of translation) complex which mediates interferon-
CC       gamma-induced transcript-selective translation inhibition in
CC       inflammation processes (PubMed:23071094). Upon interferon-gamma
CC       treatment assembles into the GAIT complex which binds to stem loop-
CC       containing GAIT elements in the 3'-UTR of diverse inflammatory mRNAs
CC       (such as ceruplasmin) and suppresses their translation
CC       (PubMed:23071094). Also plays a role in innate immunity by promoting
CC       TNF-induced NF-kappa-B activation and type I interferon production, via
CC       interaction with TRAF2 and TRAF3, respectively (By similarity).
CC       Participates in nuclear events including transcription, RNA transport,
CC       DNA replication and apoptosis. Nuclear functions are probably due to
CC       the nitrosylase activity that mediates cysteine S-nitrosylation of
CC       nuclear target proteins such as SIRT1, HDAC2 and PRKDC (By similarity).
CC       {ECO:0000250|UniProtKB:P04797, ECO:0000250|UniProtKB:P10096,
CC       ECO:0000269|PubMed:19903941, ECO:0000269|PubMed:23071094}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-glyceraldehyde 3-phosphate + phosphate + NAD(+) = (2R)-3-
CC         phospho-glyceroyl phosphate + NADH + H(+); Xref=Rhea:RHEA:10300,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:43474, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57604, ChEBI:CHEBI:57945, ChEBI:CHEBI:59776; EC=1.2.1.12;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10009,
CC         ECO:0000269|PubMed:19903941};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-nitroso-L-cysteinyl-[GAPDH] + L-cysteinyl-[protein] = L-
CC         cysteinyl-[GAPDH] + S-nitroso-L-cysteinyl-[protein];
CC         Xref=Rhea:RHEA:66684, Rhea:RHEA-COMP:10131, Rhea:RHEA-COMP:17089,
CC         Rhea:RHEA-COMP:17090, Rhea:RHEA-COMP:17091, ChEBI:CHEBI:29950,
CC         ChEBI:CHEBI:149494; Evidence={ECO:0000250|UniProtKB:P04797};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66685;
CC         Evidence={ECO:0000250|UniProtKB:P04797};
CC   -!- ACTIVITY REGULATION: Glyceraldehyde-3-phosphate dehydrogenase activity
CC       is inhibited by fumarate, via the formation of S-(2-succinyl)cysteine
CC       residues. {ECO:0000250|UniProtKB:P04797}.
CC   -!- PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-
CC       glyceraldehyde 3-phosphate: step 1/5.
CC   -!- SUBUNIT: Homotetramer (PubMed:23071094). Interacts with TPPP; the
CC       interaction is direct (By similarity). Interacts (when S-nitrosylated)
CC       with SIAH1; leading to nuclear translocation. Interacts with
CC       RILPL1/GOSPEL, leading to prevent the interaction between GAPDH and
CC       SIAH1 and prevent nuclear translocation. Interacts with CHP1; the
CC       interaction increases the binding of CHP1 with microtubules. Associates
CC       with microtubules (By similarity). Interacts with EIF1AD, USP25, PRKCI
CC       and WARS1. Interacts with phosphorylated RPL13A; inhibited by
CC       oxidatively-modified low-densitity lipoprotein (LDL(ox)) (By
CC       similarity). Component of the GAIT complex. Interacts with FKBP6;
CC       leading to inhibit GAPDH catalytic activity (PubMed:23071094).
CC       Interacts with TRAF2, promoting TRAF2 ubiquitination (By similarity).
CC       Interacts with TRAF3, promoting TRAF3 ubiquitination (By similarity).
CC       {ECO:0000250|UniProtKB:P04406, ECO:0000250|UniProtKB:P04797,
CC       ECO:0000250|UniProtKB:P10096, ECO:0000269|PubMed:23071094}.
CC   -!- INTERACTION:
CC       P16858; P23819: Gria2; NbExp=2; IntAct=EBI-444871, EBI-77538;
CC       P16858; Q08460: Kcnma1; NbExp=3; IntAct=EBI-444871, EBI-1633915;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:P04797}. Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:P04797}. Nucleus {ECO:0000250|UniProtKB:P04797}.
CC       Note=Translocates to the nucleus following S-nitrosylation and
CC       interaction with SIAH1, which contains a nuclear localization signal.
CC       Colocalizes with CHP1 to small punctate structures along the
CC       microtubules tracks. {ECO:0000250|UniProtKB:P04797}.
CC   -!- DOMAIN: The [IL]-x-C-x-x-[DE] motif is a proposed target motif for
CC       cysteine S-nitrosylation mediated by the iNOS-S100A8/A9
CC       transnitrosylase complex. {ECO:0000250|UniProtKB:P04406}.
CC   -!- PTM: ISGylated. {ECO:0000250|UniProtKB:P04406}.
CC   -!- PTM: S-nitrosylation of Cys-150 leads to interaction with SIAH1,
CC       followed by translocation to the nucleus S-nitrosylation of Cys-245 is
CC       induced by interferon-gamma and LDL(ox) implicating the iNOS-S100A8/9
CC       transnitrosylase complex and seems to prevent interaction with
CC       phosphorylated RPL13A and to interfere with GAIT complex activity (By
CC       similarity). {ECO:0000250|UniProtKB:P04406,
CC       ECO:0000250|UniProtKB:P04797}.
CC   -!- PTM: Sulfhydration at Cys-150 increases catalytic activity.
CC       {ECO:0000269|PubMed:19903941}.
CC   -!- PTM: Oxidative stress can promote the formation of high molecular
CC       weight disulfide-linked GAPDH aggregates, through a process called
CC       nucleocytoplasmic coagulation. {ECO:0000250|UniProtKB:P04406}.
CC   -!- PTM: Succination of Cys-150 and Cys-245 by the Krebs cycle intermediate
CC       fumarate, which leads to S-(2-succinyl)cysteine residues, inhibits
CC       glyceraldehyde-3-phosphate dehydrogenase activity. Fumarate
CC       concentration as well as succination of cysteine residues in GAPDH is
CC       significantly increased in muscle of diabetic mammals. It was proposed
CC       that the S-(2-succinyl)cysteine chemical modification may be a useful
CC       biomarker of mitochondrial and oxidative stress in diabetes and that
CC       succination of GAPDH and other thiol proteins by fumarate may
CC       contribute to the metabolic changes underlying the development of
CC       diabetes complications. {ECO:0000250|UniProtKB:P04797}.
CC   -!- SIMILARITY: Belongs to the glyceraldehyde-3-phosphate dehydrogenase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M32599; AAA37659.1; -; mRNA.
DR   EMBL; AK002273; BAB21979.1; -; mRNA.
DR   EMBL; AK081405; BAC38211.1; -; mRNA.
DR   EMBL; AK140794; BAE24481.1; -; mRNA.
DR   EMBL; AK144690; BAE26016.1; -; mRNA.
DR   EMBL; AK146435; BAE27169.1; -; mRNA.
DR   EMBL; AK147738; BAE28105.1; -; mRNA.
DR   EMBL; AK147891; BAE28208.1; -; mRNA.
DR   EMBL; AK160399; BAE35768.1; -; mRNA.
DR   EMBL; AK160753; BAE35989.1; -; mRNA.
DR   EMBL; AK164415; BAE37778.1; -; mRNA.
DR   EMBL; AK168217; BAE40174.1; -; mRNA.
DR   EMBL; AL662926; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC082592; AAH82592.1; -; mRNA.
DR   EMBL; BC083065; AAH83065.1; -; mRNA.
DR   EMBL; BC083079; AAH83079.1; -; mRNA.
DR   EMBL; BC083080; AAH83080.1; -; mRNA.
DR   EMBL; BC083149; AAH83149.1; -; mRNA.
DR   EMBL; BC085274; AAH85274.1; -; mRNA.
DR   EMBL; BC085275; AAH85275.1; -; mRNA.
DR   EMBL; BC085315; AAH85315.1; -; mRNA.
DR   EMBL; BC091768; AAH91768.1; -; mRNA.
DR   EMBL; BC092252; AAH92252.1; -; mRNA.
DR   EMBL; BC092264; AAH92264.1; -; mRNA.
DR   EMBL; BC092267; AAH92267.1; -; mRNA.
DR   EMBL; BC092294; AAH92294.1; -; mRNA.
DR   EMBL; BC093508; AAH93508.1; -; mRNA.
DR   EMBL; BC094037; AAH94037.1; -; mRNA.
DR   EMBL; BC095932; AAH95932.1; -; mRNA.
DR   EMBL; BC096440; AAH96440.1; -; mRNA.
DR   EMBL; BC096590; AAH96590.1; -; mRNA.
DR   EMBL; BC110311; AAI10312.1; -; mRNA.
DR   EMBL; BC145810; AAI45811.1; -; mRNA.
DR   EMBL; BC145812; AAI45813.1; -; mRNA.
DR   EMBL; DQ403054; ABD77187.1; -; mRNA.
DR   CCDS; CCDS51913.1; -.
DR   PIR; JT0553; DEMSG.
DR   RefSeq; NP_001276655.1; NM_001289726.1.
DR   RefSeq; NP_001398769.1; NM_001411840.1.
DR   RefSeq; NP_032110.1; NM_008084.4.
DR   RefSeq; XP_001476757.1; XM_001476707.5.
DR   PDB; 6LGJ; X-ray; 2.40 A; A/B/C/D=1-333.
DR   PDB; 6LGK; X-ray; 2.00 A; A/B/C/D=1-333.
DR   PDB; 6LGM; X-ray; 2.40 A; A/B/C/D=1-333.
DR   PDBsum; 6LGJ; -.
DR   PDBsum; 6LGK; -.
DR   PDBsum; 6LGM; -.
DR   AlphaFoldDB; P16858; -.
DR   SMR; P16858; -.
DR   BioGRID; 199829; 62.
DR   BioGRID; 785307; 3.
DR   DIP; DIP-31404N; -.
DR   FunCoup; P16858; 1408.
DR   IntAct; P16858; 24.
DR   MINT; P16858; -.
DR   STRING; 10090.ENSMUSP00000113942; -.
DR   ChEMBL; CHEMBL3309048; -.
DR   MoonProt; P16858; -.
DR   GlyGen; P16858; 3 sites, 1 O-linked glycan (3 sites).
DR   iPTMnet; P16858; -.
DR   MetOSite; P16858; -.
DR   PhosphoSitePlus; P16858; -.
DR   SwissPalm; P16858; -.
DR   REPRODUCTION-2DPAGE; P16858; -.
DR   REPRODUCTION-2DPAGE; Q5U410; -.
DR   jPOST; P16858; -.
DR   PaxDb; 10090-ENSMUSP00000113942; -.
DR   ProteomicsDB; 267504; -.
DR   Pumba; P16858; -.
DR   TopDownProteomics; P16858; -.
DR   DNASU; 14433; -.
DR   Ensembl; ENSMUST00000073605.15; ENSMUSP00000073289.9; ENSMUSG00000057666.19.
DR   Ensembl; ENSMUST00000118875.8; ENSMUSP00000113213.2; ENSMUSG00000057666.19.
DR   GeneID; 14433; -.
DR   KEGG; mmu:14433; -.
DR   UCSC; uc007igj.1; mouse.
DR   AGR; MGI:95640; -.
DR   CTD; 2597; -.
DR   MGI; MGI:95640; Gapdh.
DR   VEuPathDB; HostDB:ENSMUSG00000057666; -.
DR   eggNOG; KOG0657; Eukaryota.
DR   GeneTree; ENSGT00940000153298; -.
DR   HOGENOM; CLU_030140_0_1_1; -.
DR   InParanoid; P16858; -.
DR   OMA; YGYTCNM; -.
DR   OrthoDB; 9553738at2759; -.
DR   PhylomeDB; P16858; -.
DR   BRENDA; 1.2.1.12; 3474.
DR   Reactome; R-MMU-70171; Glycolysis.
DR   Reactome; R-MMU-70263; Gluconeogenesis.
DR   SABIO-RK; P16858; -.
DR   UniPathway; UPA00109; UER00184.
DR   BioGRID-ORCS; 14433; 27 hits in 78 CRISPR screens.
DR   CD-CODE; CE726F99; Postsynaptic density.
DR   ChiTaRS; Gapdh; mouse.
DR   PRO; PR:P16858; -.
DR   Proteomes; UP000000589; Chromosome 6.
DR   RNAct; P16858; protein.
DR   Bgee; ENSMUSG00000057666; Expressed in epiblast (generic) and 123 other cell types or tissues.
DR   ExpressionAtlas; P16858; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:MGI.
DR   GO; GO:0097452; C:GAIT complex; IDA:UniProtKB.
DR   GO; GO:0031906; C:late endosome lumen; TAS:Reactome.
DR   GO; GO:0015630; C:microtubule cytoskeleton; ISS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; HDA:MGI.
DR   GO; GO:0043209; C:myelin sheath; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0004365; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity; IDA:UniProtKB.
DR   GO; GO:0008017; F:microtubule binding; ISS:UniProtKB.
DR   GO; GO:0051287; F:NAD binding; IEA:InterPro.
DR   GO; GO:0050661; F:NADP binding; IEA:InterPro.
DR   GO; GO:0035605; F:peptidyl-cysteine S-nitrosylase activity; ISS:UniProtKB.
DR   GO; GO:0061621; P:canonical glycolysis; IDA:MGI.
DR   GO; GO:0006094; P:gluconeogenesis; IDA:MGI.
DR   GO; GO:0046166; P:glyceraldehyde-3-phosphate biosynthetic process; ISO:MGI.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; ISS:UniProtKB.
DR   GO; GO:0017148; P:negative regulation of translation; IDA:UniProtKB.
DR   GO; GO:0051402; P:neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:0035606; P:peptidyl-cysteine S-trans-nitrosylation; ISS:UniProtKB.
DR   GO; GO:0043123; P:positive regulation of canonical NF-kappaB signal transduction; ISS:UniProtKB.
DR   GO; GO:0032481; P:positive regulation of type I interferon production; ISS:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; ISS:UniProtKB.
DR   CDD; cd18126; GAPDH_I_C; 1.
DR   CDD; cd05214; GAPDH_I_N; 1.
DR   FunFam; 3.30.360.10:FF:000001; Glyceraldehyde-3-phosphate dehydrogenase; 1.
DR   FunFam; 3.40.50.720:FF:001161; Glyceraldehyde-3-phosphate dehydrogenase; 1.
DR   FunFam; 3.40.50.720:FF:000636; Glyceraldehyde-3-phosphate dehydrogenase 2, cytosolic; 1.
DR   Gene3D; 3.30.360.10; Dihydrodipicolinate Reductase, domain 2; 1.
DR   Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 1.
DR   InterPro; IPR020831; GlycerAld/Erythrose_P_DH.
DR   InterPro; IPR020830; GlycerAld_3-P_DH_AS.
DR   InterPro; IPR020829; GlycerAld_3-P_DH_cat.
DR   InterPro; IPR020828; GlycerAld_3-P_DH_NAD(P)-bd.
DR   InterPro; IPR006424; Glyceraldehyde-3-P_DH_1.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   NCBIfam; TIGR01534; GAPDH-I; 1.
DR   PANTHER; PTHR10836; GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE; 1.
DR   PANTHER; PTHR10836:SF111; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; 1.
DR   Pfam; PF02800; Gp_dh_C; 1.
DR   Pfam; PF00044; Gp_dh_N; 1.
DR   PIRSF; PIRSF000149; GAP_DH; 1.
DR   PRINTS; PR00078; G3PDHDRGNASE.
DR   SMART; SM00846; Gp_dh_N; 1.
DR   SUPFAM; SSF55347; Glyceraldehyde-3-phosphate dehydrogenase-like, C-terminal domain; 1.
DR   SUPFAM; SSF51735; NAD(P)-binding Rossmann-fold domains; 1.
DR   PROSITE; PS00071; GAPDH; 1.
DR   TreeFam; TF300533; -.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ADP-ribosylation; Apoptosis; Cytoplasm;
KW   Cytoskeleton; Direct protein sequencing; Glycolysis; Immunity;
KW   Innate immunity; Isopeptide bond; Methylation; NAD; Nucleus;
KW   Oxidoreductase; Phosphoprotein; Reference proteome; S-nitrosylation;
KW   Transferase; Translation regulation; Ubl conjugation.
FT   CHAIN           1..333
FT                   /note="Glyceraldehyde-3-phosphate dehydrogenase"
FT                   /id="PRO_0000145490"
FT   REGION          1..146
FT                   /note="Interaction with WARS1"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOTIF           243..248
FT                   /note="[IL]-x-C-x-x-[DE] motif"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   ACT_SITE        150
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10009"
FT   BINDING         11..12
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   BINDING         33
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   BINDING         78
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   BINDING         120
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   BINDING         149..151
FT                   /ligand="D-glyceraldehyde 3-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:59776"
FT                   /evidence="ECO:0000250|UniProtKB:P22513"
FT   BINDING         180
FT                   /ligand="D-glyceraldehyde 3-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:59776"
FT                   /evidence="ECO:0000250|UniProtKB:P22513"
FT   BINDING         209..210
FT                   /ligand="D-glyceraldehyde 3-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:59776"
FT                   /evidence="ECO:0000250|UniProtKB:P22513"
FT   BINDING         232
FT                   /ligand="D-glyceraldehyde 3-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:59776"
FT                   /evidence="ECO:0000250|UniProtKB:P22513"
FT   BINDING         314
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   SITE            177
FT                   /note="Activates thiol group during catalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         3
FT                   /note="N6,N6-dimethyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         7
FT                   /note="Deamidated asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         40
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         59
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         62
FT                   /note="Deamidated asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         64
FT                   /note="N6,N6-dimethyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         68
FT                   /note="Deamidated asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         73
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         120
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         146
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         147
FT                   /note="Deamidated asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         149
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         150
FT                   /note="ADP-ribosylcysteine; by autocatalysis; in
FT                   irreversibly inhibited form"
FT                   /evidence="ECO:0000250|UniProtKB:P04797"
FT   MOD_RES         150
FT                   /note="Cysteine persulfide"
FT                   /evidence="ECO:0000269|PubMed:19903941"
FT   MOD_RES         150
FT                   /note="S-(2-succinyl)cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P04797"
FT   MOD_RES         150
FT                   /note="S-nitrosocysteine; in reversibly inhibited form"
FT                   /evidence="ECO:0000250|UniProtKB:P04797"
FT   MOD_RES         151
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         153
FT                   /note="Deamidated asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         175
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         180
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         182
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         192
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         192
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         192
FT                   /note="N6-malonyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         209
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         213
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         213
FT                   /note="N6-malonyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         217
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         223
FT                   /note="Deamidated asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         225
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         225
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         227
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         235
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         239
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         245
FT                   /note="S-(2-succinyl)cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P04797"
FT   MOD_RES         245
FT                   /note="S-nitrosocysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         252
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         258
FT                   /note="N6,N6-dimethyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         261
FT                   /note="N6,N6-dimethyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         310
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         314
FT                   /note="Deamidated asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         331
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MOD_RES         332
FT                   /note="N6,N6-dimethyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   CROSSLNK        184
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P04406"
FT   MUTAGEN         150
FT                   /note="C->S: Abolishes sulfhydration and induces impaired
FT                   enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:19903941"
FT   CONFLICT        3
FT                   /note="K -> E (in Ref. 2; BAE40174)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        30
FT                   /note="A -> V (in Ref. 4; AAH92267)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        82
FT                   /note="N -> S (in Ref. 2; BAE35989)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        84
FT                   /note="K -> E (in Ref. 2; BAE40174)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        89
FT                   /note="G -> S (in Ref. 2; BAE26016)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        91
FT                   /note="E -> K (in Ref. 2; BAE35989)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        134
FT                   /note="N -> D (in Ref. 4; AAH85315)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        195
FT                   /note="R -> C (in Ref. 4; AAH85315)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        300
FT                   /note="A -> S (in Ref. 4; AAH85315)"
FT                   /evidence="ECO:0000305"
FT   STRAND          3..8
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   HELIX           11..22
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   STRAND          25..32
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   HELIX           38..46
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   TURN            49..51
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   STRAND          58..61
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   STRAND          64..67
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   STRAND          70..75
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   HELIX           80..82
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   HELIX           85..88
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   STRAND          92..95
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   STRAND          97..99
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   HELIX           103..106
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   HELIX           108..111
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   STRAND          115..121
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   STRAND          124..126
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   TURN            131..133
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   HELIX           135..137
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   STRAND          143..146
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   HELIX           150..166
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   STRAND          168..178
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   STRAND          183..187
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   HELIX           194..197
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   TURN            200..202
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   STRAND          205..207
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   HELIX           211..218
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   HELIX           220..222
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   TURN            223..225
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   STRAND          226..234
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   STRAND          239..249
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   HELIX           253..265
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   TURN            266..271
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   STRAND          272..275
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   HELIX           281..284
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   STRAND          290..294
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   HELIX           295..297
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   STRAND          299..302
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   STRAND          305..312
FT                   /evidence="ECO:0007829|PDB:6LGK"
FT   HELIX           316..331
FT                   /evidence="ECO:0007829|PDB:6LGK"
SQ   SEQUENCE   333 AA;  35810 MW;  F25131EFFA9F2BD6 CRC64;
     MVKVGVNGFG RIGRLVTRAA ICSGKVEIVA INDPFIDLNY MVYMFQYDST HGKFNGTVKA
     ENGKLVINGK PITIFQERDP TNIKWGEAGA EYVVESTGVF TTMEKAGAHL KGGAKRVIIS
     APSADAPMFV MGVNHEKYDN SLKIVSNASC TTNCLAPLAK VIHDNFGIVE GLMTTVHAIT
     ATQKTVDGPS GKLWRDGRGA AQNIIPASTG AAKAVGKVIP ELNGKLTGMA FRVPTPNVSV
     VDLTCRLEKP AKYDDIKKVV KQASEGPLKG ILGYTEDQVV SCDFNSNSHS STFDAGAGIA
     LNDNFVKLIS WYDNEYGYSN RVVDLMAYMA SKE
//
